Thursday, January 15, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Market Experts Bullish on MSCI Ahead of Earnings Report

Felix Baarz by Felix Baarz
January 15, 2026
in Analysis, Earnings, S&P 500
0
Msci Stock
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

A series of price target upgrades in mid-January has bolstered confidence in the financial data provider MSCI. Market strategists point to accelerating subscription growth, underpinned by the firm’s resilient recurring revenue model. The upcoming quarterly results will be a key test for this optimistic sentiment.

Key Data Points:
* Recent Share Price: The stock closed at $594.79 in the last session, marking a gain of 1.25%.
* Upcoming Report: MSCI is scheduled to release its Q4 and full-year 2025 financial figures before the market opens on Wednesday, January 28. A conference call for investors is set for 11:00 a.m. Eastern Time.
* Earnings Forecast: The consensus estimate for quarterly earnings per share (EPS) stands at $4.59.
* Analyst Price Target: The average 12-month price target among covering analysts is $650.13.
* One-Year Performance: Over the past twelve months, the share price has declined by 1.96%.

A Wave of Upgraded Forecasts

The positive shift in analyst outlook is evidenced by several specific actions. On January 13, Raymond James increased its target price to $690 from $680, reaffirming its “Outperform” rating on the equity. The following day, Wells Fargo raised its target to $590, up from $570, while maintaining an “Equalweight” stance. This adjustment suggests an improved view of the company’s fundamentals without a change in the overall recommendation.

Should investors sell immediately? Or is it worth buying Msci?

Supporting this view, RBC Capital Markets highlighted in mid-January that MSCI is demonstrating building momentum in its subscription business. The firm sees this as creating a solid foundation for future recurring income streams. Collectively, these revisions indicate a broad-based reassessment of the company’s growth trajectory, with multiple researchers anticipating a medium-term reacceleration of subscription growth into double-digit percentages.

All Eyes on the January 28 Earnings Release

The immediate focus for investors is squarely on the fourth-quarter report due at the end of January. The consensus EPS expectation of $4.59 will serve as a benchmark. More critically, the market will scrutinize whether the reported figures reflect the anticipated subscription momentum and what guidance management provides for the coming periods.

Should the results meet or exceed expectations and confirm an acceleration in subscription growth, the current optimistic analyst stance and elevated price targets are likely to be validated. Conversely, if the earnings disappoint or MSCI reports weaker subscriber metrics, a downward revision of targets and a recalibration of growth expectations would be a probable outcome. The report will ultimately determine if the recent analyst confidence is well-founded.

Ad

Msci Stock: Buy or Sell?! New Msci Analysis from January 15 delivers the answer:

The latest Msci figures speak for themselves: Urgent action needed for Msci investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from January 15.

Msci: Buy or sell? Read more here...

Tags: MSCI
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Cassava Sciences Stock
Analysis

Cassava Sciences Faces Critical Juncture After Alzheimer’s Trial Failure

January 15, 2026
Deere Stock
Analysis

Diverging Views Emerge on Deere’s Stock Trajectory

January 15, 2026
Bionxt Solutions Stock
Analysis

Bionxt Solutions Shares Face Selling Pressure After Rally

January 15, 2026
Next Post
Deere Stock

Diverging Views Emerge on Deere's Stock Trajectory

Cassava Sciences Stock

Cassava Sciences Faces Critical Juncture After Alzheimer's Trial Failure

Apex Critical Metals Stock

Major Shareholder Deepens Stake in Apex Critical Metals

Recommended

Fossil Stock

Fossil’s Fate Hangs in the Balance as Court Decision Looms

2 months ago
Oil and Gas Producers Markets and money

ChampionX Acquires Artificial Lift Performance Limited A Strategic Milestone in Production Optimization

2 years ago
Intellia Therapeutics Stock

Intellia Therapeutics Faces Critical Setback Following Patient Death in Clinical Trial

2 months ago
Marvell Technology Stock

Marvell Technology Shares Face Pressure as AI Sector Shows Cracks

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Market Experts Bullish on MSCI Ahead of Earnings Report

Bionxt Solutions Shares Face Selling Pressure After Rally

Coca-Cola Charts New Course with 2026 Leadership and Strategic Overhaul

Realty Income: Institutional Confidence Meets Dividend Consistency

Centrus Energy: Assessing the Valuation Premium After Major Government Contract

Asian Bitcoin Proxy Attracts Major Investor Endorsement Amid Macroeconomic Forecast

Trending

Apex Critical Metals Stock
Commodities

Major Shareholder Deepens Stake in Apex Critical Metals

by Robert Sasse
January 15, 2026
0

A significant anchor investor has reinforced its commitment to Apex Critical Metals, sending a powerful signal of...

Cassava Sciences Stock

Cassava Sciences Faces Critical Juncture After Alzheimer’s Trial Failure

January 15, 2026
Deere Stock

Diverging Views Emerge on Deere’s Stock Trajectory

January 15, 2026
Msci Stock

Market Experts Bullish on MSCI Ahead of Earnings Report

January 15, 2026
Bionxt Solutions Stock

Bionxt Solutions Shares Face Selling Pressure After Rally

January 15, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Major Shareholder Deepens Stake in Apex Critical Metals
  • Cassava Sciences Faces Critical Juncture After Alzheimer’s Trial Failure
  • Diverging Views Emerge on Deere’s Stock Trajectory

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com